These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 23148752)

  • 1. Dendritic cell-based tumor vaccinations in epithelial ovarian cancer: a systematic review.
    Tanyi JL; Chu CS
    Immunotherapy; 2012 Oct; 4(10):995-1009. PubMed ID: 23148752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma.
    Sarivalasis A; Boudousquié C; Balint K; Stevenson BJ; Gannon PO; Iancu EM; Rossier L; Martin Lluesma S; Mathevet P; Sempoux C; Coukos G; Dafni U; Harari A; Bassani-Sternberg M; Kandalaft LE
    J Transl Med; 2019 Nov; 17(1):391. PubMed ID: 31771601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendritic Cells Loaded with Heat Shock-Conditioned Ovarian Epithelial Carcinoma Cell Lysates Elicit T Cell-Dependent Antitumor Immune Responses
    Flores I; Hevia D; Tittarelli A; Soto D; Rojas-Sepúlveda D; Pereda C; Tempio F; Fuentes C; Falcón-Beas C; Gatica J; Falcón-Beas F; Galindo M; Salazar-Onfray F; González FE; López MN
    J Immunol Res; 2019; 2019():9631515. PubMed ID: 31886313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding dendritic cell immunotherapy in ovarian cancer.
    Drakes ML; Stiff PJ
    Expert Rev Anticancer Ther; 2016 Jun; 16(6):643-52. PubMed ID: 27078511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized dendritic cell-based tumor immunotherapy.
    Janikashvili N; Larmonier N; Katsanis E
    Immunotherapy; 2010 Jan; 2(1):57-68. PubMed ID: 20161666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of dendritic cell autovaccine on the treatment outcome in patients with ovarian cancer].
    Khranovskaia NN; Grinevich IuA; Potebnia GP; Vorod'eva LI; Svintsitskiĭ VS; Tsin NP; Skachkova OV; Sit'ko VV; Lisovenko GS; Tanacienko OA; Svergun NN; Mel'nik VA; Gorbach AI; Nikulina VV
    Vopr Onkol; 2012; 58(6):781-6. PubMed ID: 23600304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.
    Chiriva-Internati M; Mirandola L; Kast WM; Jenkins MR; Cobos E; Cannon MJ
    Int Rev Immunol; 2011; 30(2-3):71-86. PubMed ID: 21557635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic Cell Vaccines in Ovarian Cancer.
    Zhang X; He T; Li Y; Chen L; Liu H; Wu Y; Guo H
    Front Immunol; 2020; 11():613773. PubMed ID: 33584699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced clinical trials of dendritic cell vaccines in ovarian cancer.
    Guo Q; Yang Q; Li J; Liu G; Nikoulin I; Jia S
    J Investig Med; 2020 Oct; 68(7):1223-1227. PubMed ID: 32718940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic cell-based vaccines: clinical applications in breast cancer.
    Gelao L; Criscitiello C; Esposito A; De Laurentiis M; Fumagalli L; Locatelli MA; Minchella I; Santangelo M; De Placido S; Goldhirsch A; Curigliano G
    Immunotherapy; 2014; 6(3):349-60. PubMed ID: 24762078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of immunotherapy efficiency in mouse CaO-1 ovarian carcinoma treated by vaccines based on dendritic cells.
    Sitdikova SM; Kiselevskii MV; Sel'chuk VY; Amandzholov BS; Kurbatova EA; Donenko FV
    Bull Exp Biol Med; 2009 Feb; 147(2):226-8. PubMed ID: 19513427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppressive factor blockade in dendritic cells via siRNAs results in objective clinical responses.
    Sioud M; Mobergslien A; Sæbøe-Larssen S
    Methods Mol Biol; 2015; 1218():269-76. PubMed ID: 25319657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer immunotherapy using dendritic/tumour-fusion vaccine induces elevation of serum anti-nuclear antibody with better clinical responses.
    Homma S; Sagawa Y; Ito M; Ohno T; Toda G
    Clin Exp Immunol; 2006 Apr; 144(1):41-7. PubMed ID: 16542363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results.
    Mastelic-Gavillet B; Balint K; Boudousquie C; Gannon PO; Kandalaft LE
    Front Immunol; 2019; 10():766. PubMed ID: 31031762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cell vaccines in melanoma: from promise to proof?
    Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
    Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cell rehab: new strategies to unleash therapeutic immunity in ovarian cancer.
    Chae CS; Teran-Cabanillas E; Cubillos-Ruiz JR
    Cancer Immunol Immunother; 2017 Aug; 66(8):969-977. PubMed ID: 28214928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active cellular immunotherapy of ovarian cancer using dendritic cells].
    Brtnicky T; Podrazil M; Bartunkova J; Spíšek R; Rob L
    Ceska Gynekol; 2012 Jun; 77(3):215-20. PubMed ID: 22779721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic Cell Vaccines.
    Sabado RL; Meseck M; Bhardwaj N
    Methods Mol Biol; 2016; 1403():763-77. PubMed ID: 27076166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care.
    Bapsy PP; Sharan B; Kumar C; Das RP; Rangarajan B; Jain M; Suresh Attili VS; Subramanian S; Aggarwal S; Srivastava M; Vaid A
    Cytotherapy; 2014 Feb; 16(2):234-44. PubMed ID: 24438902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.